Adaptimmune Therapeutics PLC financial data

Symbol
ADAP on Nasdaq
Location
60 Jubilee Avenue, Milton Park, Abingdon, Oxfordshire, United Kingdom
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2025 - Aug 13, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 266 % -9.09%
Quick Ratio 14 %
Debt-to-equity -5.25K % -1531%
Return On Assets -79.7 % -218%
Operating Margin -252 % -363%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 1.59B shares +3.64%
Common Stock, Shares, Outstanding 1.59B shares +3.66%
Entity Public Float 231M USD +20.7%
Common Stock, Value, Issued 2.16M USD +3.51%
Weighted Average Number of Shares Outstanding, Basic 1.58B shares +3.33%
Weighted Average Number of Shares Outstanding, Diluted 1.58B shares +1.63%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 13.7M USD -89.3%
Revenue from Contract with Customer, Excluding Assessed Tax 65.1M USD -54%
Research and Development Expense 125M USD -14.6%
General and Administrative Expense 71.9M USD -0.89%
Costs and Expenses 229M USD +4.94%
Operating Income (Loss) -164M USD -113%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -166M USD -133%
Income Tax Expense (Benefit) 3.71M USD +243%
Net Income (Loss) Attributable to Parent -170M USD -134%
Earnings Per Share, Basic 0 USD/shares -140%
Earnings Per Share, Diluted 0 USD/shares -83.3%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 26.1M USD -87.7%
Accounts Receivable, after Allowance for Credit Loss, Current 9.31M USD +299%
Inventory, Net 11.4M USD
Other Assets, Current 3.52M USD +6.97%
Assets, Current 78.1M USD -69.2%
Property, Plant and Equipment, Net 28.2M USD -38.6%
Operating Lease, Right-of-Use Asset 18.7M USD +2.99%
Intangible Assets, Net (Excluding Goodwill) 3.81M USD +282%
Other Assets, Noncurrent 94K USD
Assets 131M USD -59.4%
Accounts Payable, Current 9.42M USD +25.4%
Employee-related Liabilities, Current 7.59M USD -21.2%
Accrued Liabilities, Current 24.5M USD -20.5%
Contract with Customer, Liability, Current 10.7M USD -72.1%
Liabilities, Current 51.5M USD -37.2%
Contract with Customer, Liability, Noncurrent 101M USD
Operating Lease, Liability, Noncurrent 18.5M USD +8.13%
Other Liabilities, Noncurrent 4.49M USD +212%
Liabilities 202M USD -10.6%
Accumulated Other Comprehensive Income (Loss), Net of Tax -10.6M USD -211%
Retained Earnings (Accumulated Deficit) -1.17B USD -16.9%
Stockholders' Equity Attributable to Parent -71M USD -174%
Liabilities and Equity 131M USD -59.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -66.6M USD -108%
Net Cash Provided by (Used in) Financing Activities -25.3M USD -187%
Net Cash Provided by (Used in) Investing Activities 41.2M USD
Common Stock, Shares Authorized 2.11B shares +3.38%
Common Stock, Shares, Issued 1.59B shares +3.66%
Common Stock, Par or Stated Value Per Share 0 GBP/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -50.2M USD -1339%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 27.8M USD -87.1%
Deferred Tax Assets, Valuation Allowance 309M USD +4.94%
Deferred Tax Assets, Gross 313M USD +3.67%
Operating Lease, Liability 23M USD +2.73%
Depreciation 2.29M USD -17.3%
Payments to Acquire Property, Plant, and Equipment 1.2M USD +1079%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -177M USD -143%
Lessee, Operating Lease, Liability, to be Paid 29.8M USD +12.4%
Property, Plant and Equipment, Gross 83.2M USD -14.2%
Operating Lease, Liability, Current 4.51M USD -14.7%
Lessee, Operating Lease, Liability, to be Paid, Year Two 4.39M USD -21.1%
Lessee, Operating Lease, Liability, to be Paid, Year One 4.77M USD +39.7%
Operating Lease, Weighted Average Discount Rate, Percent 0.1 pure +25.6%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 6.84M USD +64%
Lessee, Operating Lease, Liability, to be Paid, Year Three 4.44M USD +1.76%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 4.5M USD -19.2%
Additional Paid in Capital 1.11B USD +0.88%
Deferred Tax Assets, Net of Valuation Allowance 3.61M USD -49.1%
Share-based Payment Arrangement, Expense -1.07M USD -109%